Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey

January 2011
BMC Public Health;2011, Vol. 11 Issue 1, p754
Academic Journal
The article presents a research conducted on examining the prevalence of different metabolical phenotypes of obesity, by using different risk scores. It investigates how the metabolic syndrome (MetS) definition discriminates between unhealthy and healthy metabolic phenotypes in different obesity classes. It mentions that Finnish type 2 diabetes (FIN-D2D) survey was used to conduct the research. It concludes that undetected Type 2 diabetes was more prevalent among those with MetS.


Related Articles

  • METABOLIC SYNDROME IN CLINICAL PRACTICE: CONSIDERATIONS ON DIAGNOSTIC CRITERIA AND PREVALENCE. Vasilescu, R. // Therapeutics, Pharmacology & Clinical Toxicology;2011, Vol. 15 Issue 2, p93 

    The metabolic syndrome is defined as an association of risk factors of metabolic origin, combined with a heightened risk for cardiovascular diseases and for type 2 diabetes mellitus. The pathogenesis of the metabolic syndrome is multifactorial, the main risk factors being: obesity (abdominal...

  • Genetic Variation in the PPAR-δ Gene (PPARD) Reduces the Response to Lifestyle Intervention. Thamer, Claus; Machann, Jurgen; Schafer, Silke; Machicao, Fausto; Stefan, Norbert; Staiger, Harald; Bottcher, Michael; Claussen, Claus; Schick, Fritz; Fritsche, Andreas; Haring, Hans // Diabetes;Jun2007 Supplement 1, Vol. 56, pA278 

    Single nucleotide polymorphisms (SNPs) in the peroxisome proliferator activated receptor-δ gene (PPARD) predict the conversion from impaired glucose tolerance to type 2 diabetes. The mechanism possibly involves fatty acid oxidation. We could show that SNPs in PPARD are associated with...

  • Differentiating Insulin-Resistant and Insulin-Deficient Phenotypes in Adults Aged 48-94 Years with Abnormal Glucose Tolerance. Racette, Susan B.; Weiss, Edward P.; Villareal, Dennis T.; Holloszy, John O. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA339 

    Impaired glucose tolerance and type 2 diabetes mellitus are characterized by insulin resistance and/or relative insulin deficiency. We explored the physiologic differences between adults with insulin resistance and insulin deficiency who were matched for glucose tolerance and lean body mass....

  • Prevalence of Metabolic Syndrome among workers of Dolomite Mine at Madharam, Khammam District Andhra Pradesh. Madhav, K. V. Phani; Mallavarapu, Sandeep; Baer, Philip Ravi Kumar // Medica Innovatica;Dec2013, Vol. 2 Issue 2, p40 

    Introduction: Metabolic syndrome (MS) is a combination of disorders that, when occurring together, increase the risk of developing cardiovascular disease and Diabetes. The prevalence of the components of MS is increased in obesity and is associated with atherothrombotic complications in micro-...

  • Current Hypertension Reviews, Hot Topics "Obesity, Hypertension, and the Metabolic Syndrome". Masuo, Kazuko // Current Hypertension Reviews;May2010, Vol. 6 Issue 2, p72 

    No abstract available.

  • Leptin Concentrations in African Blacks with Metabolic Syndrome and Type 2 Diabetes Mellitus. Fabian, Unyime Aniekpon; Charles-Davies, Mabel Ayebatonyo; Adebusuyi, Jane Roli; Ebesunun, Maria Onomhaguan; Ajobo, Babatunde Mohammed; Hassan, Olufunke Olayemi; Adigun, Kehinde; Owolabi, Mayowa Ojo; Oyewole, Oyediran Emmanuel; Olaniyi, John Ayodele; Fasanmade, Adesoji Adedipe; Akinlade, Kehinde Sola; Arinola, Olatubosun Ganiyu; Agbedana, Emmanuel Oluyemi // Journal of US-China Medical Science;Aug2011, Vol. 8 Issue 8, p493 

    Background: Mortality rate from metabolic/cardiometabolic syndromes (MS/CMS) and type 2 diabetes mellitus (DM2) are highly prevalent in African blacks known with higher mortality from cardiovascular diseases than caucasians. Leptin, a satiety-regulating hormone increases in obesity and is...

  • Human resistin and the RELM of Inflammation in diabesity. Al Hannan, Fatima; Culligan, Kevin Gerard // Diabetology & Metabolic Syndrome;2015, Vol. 7 Issue 1, p1 

    The initial discovery of resistin and resistin-like molecules (RELMs) in rodents suggested a role for these adipocytokines in molecular linkage of obesity, Type 2 Diabetes mellitus and metabolic syndrome. Since then, it became apparent that the story of resistin and RELMs was very much of mice...

  • Natural Products for the Treatment of Obesity, Metabolic Syndrome, and Type 2 Diabetes 2014. Thounaojam, Menaka C.; Nammi, Srinivas; Jadeja, Ravirajsinh // Evidence-based Complementary & Alternative Medicine (eCAM);2015, p1 

    No abstract available.

  • Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease. Vinciguerra, Federica; Baratta, Roberto; Farina, Maria; Tita, Patrizia; Padova, Giuseppa; Vigneri, Riccardo; Frittitta, Lucia // Acta Diabetologica;Jun2013, Vol. 50 Issue 3, p443 

    The prevalence of very severe obesity has increased progressively and faster than other classes of obesity over the last years. It is unclear whether the prevalence of obesity-related complications and health risks increases progressively or reaches a plateau above a certain degree of obesity....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics